Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Director Lori Anne Kunkel Sells 10,000 Shares of Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Director Lori Anne Kunkel sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $34.54, for a total transaction of $345,400.00. Following the completion of the transaction, the director owned 51,884 shares in the company, valued at approximately $1,792,073.36. This trade represents a 16.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bitwise MARA Option Income Strategy ETF Trading Down 0.8%

IMRA stock opened at $16.58 on Wednesday. The company’s 50 day moving average is $15.88 and its 200 day moving average is $15.95. The stock has a market cap of $3.15 million, a price-to-earnings ratio of 331.60 and a beta of 2.88. Bitwise MARA Option Income Strategy ETF has a 1-year low of $11.99 and a 1-year high of $54.94.

Bitwise MARA Option Income Strategy ETF Company Profile

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.